A pharmacokinetic PET study of NK(1) receptor occupancy

Stefano Zamuner, Eugenii A Rabiner, Sofia A Fernandes, Massimo Bani, Roger N Gunn, Roberto Gomeni, Emilangelo Ratti, Vincent J Cunningham

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

There is growing recognition of the importance of integrating drug occupancy data acquired by positron emission tomography (PET) with the plasma pharmacokinetics of the drug, in order to establish proper dose selection in subsequent clinical trials. Here we present a study in human subjects of the occupancy of NK(1) receptors achieved following different doses of casopitant, a selective NK(1) antagonist.
Original languageEnglish
Pages (from-to)226-235
Number of pages10
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume39
Issue number2
Early online date13 Oct 2011
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Neurokinin-1 Receptors
Positron-Emission Tomography
Pharmacokinetics
Pharmaceutical Preparations
Clinical Trials
casopitant

Keywords

  • positron emission tomography
  • pharmacokinetics
  • NK1 receptors
  • kinetic modelling
  • population approach

Cite this

Zamuner, S., Rabiner, E. A., Fernandes, S. A., Bani, M., Gunn, R. N., Gomeni, R., ... Cunningham, V. J. (2012). A pharmacokinetic PET study of NK(1) receptor occupancy. European Journal of Nuclear Medicine and Molecular Imaging, 39(2), 226-235. https://doi.org/10.1007/s00259-011-1954-2

A pharmacokinetic PET study of NK(1) receptor occupancy. / Zamuner, Stefano; Rabiner, Eugenii A; Fernandes, Sofia A; Bani, Massimo; Gunn, Roger N; Gomeni, Roberto; Ratti, Emilangelo; Cunningham, Vincent J.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 39, No. 2, 02.2012, p. 226-235.

Research output: Contribution to journalArticle

Zamuner, S, Rabiner, EA, Fernandes, SA, Bani, M, Gunn, RN, Gomeni, R, Ratti, E & Cunningham, VJ 2012, 'A pharmacokinetic PET study of NK(1) receptor occupancy', European Journal of Nuclear Medicine and Molecular Imaging, vol. 39, no. 2, pp. 226-235. https://doi.org/10.1007/s00259-011-1954-2
Zamuner, Stefano ; Rabiner, Eugenii A ; Fernandes, Sofia A ; Bani, Massimo ; Gunn, Roger N ; Gomeni, Roberto ; Ratti, Emilangelo ; Cunningham, Vincent J. / A pharmacokinetic PET study of NK(1) receptor occupancy. In: European Journal of Nuclear Medicine and Molecular Imaging. 2012 ; Vol. 39, No. 2. pp. 226-235.
@article{e47f24edd3ed4ec0bfae8ab9f57deef8,
title = "A pharmacokinetic PET study of NK(1) receptor occupancy",
abstract = "There is growing recognition of the importance of integrating drug occupancy data acquired by positron emission tomography (PET) with the plasma pharmacokinetics of the drug, in order to establish proper dose selection in subsequent clinical trials. Here we present a study in human subjects of the occupancy of NK(1) receptors achieved following different doses of casopitant, a selective NK(1) antagonist.",
keywords = "positron emission tomography, pharmacokinetics, NK1 receptors, kinetic modelling, population approach",
author = "Stefano Zamuner and Rabiner, {Eugenii A} and Fernandes, {Sofia A} and Massimo Bani and Gunn, {Roger N} and Roberto Gomeni and Emilangelo Ratti and Cunningham, {Vincent J}",
year = "2012",
month = "2",
doi = "10.1007/s00259-011-1954-2",
language = "English",
volume = "39",
pages = "226--235",
journal = "European Journal of Nuclear Medicine and Molecular Imaging",
issn = "1619-7070",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - A pharmacokinetic PET study of NK(1) receptor occupancy

AU - Zamuner, Stefano

AU - Rabiner, Eugenii A

AU - Fernandes, Sofia A

AU - Bani, Massimo

AU - Gunn, Roger N

AU - Gomeni, Roberto

AU - Ratti, Emilangelo

AU - Cunningham, Vincent J

PY - 2012/2

Y1 - 2012/2

N2 - There is growing recognition of the importance of integrating drug occupancy data acquired by positron emission tomography (PET) with the plasma pharmacokinetics of the drug, in order to establish proper dose selection in subsequent clinical trials. Here we present a study in human subjects of the occupancy of NK(1) receptors achieved following different doses of casopitant, a selective NK(1) antagonist.

AB - There is growing recognition of the importance of integrating drug occupancy data acquired by positron emission tomography (PET) with the plasma pharmacokinetics of the drug, in order to establish proper dose selection in subsequent clinical trials. Here we present a study in human subjects of the occupancy of NK(1) receptors achieved following different doses of casopitant, a selective NK(1) antagonist.

KW - positron emission tomography

KW - pharmacokinetics

KW - NK1 receptors

KW - kinetic modelling

KW - population approach

U2 - 10.1007/s00259-011-1954-2

DO - 10.1007/s00259-011-1954-2

M3 - Article

C2 - 21993526

VL - 39

SP - 226

EP - 235

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

SN - 1619-7070

IS - 2

ER -